retatrutide maximum dose clinical trials Crémieux on X: "I get this question pretty often now: How do I to minimize side effects? I asked trial participants and long-time users, and I reassembled what I think retatrutide trial doses just posted

Every new approval expands the market Better insurance coverage- Right now, many plans dont cover GLP-1s for obesity

Carnitine deficiency manifests as weakness, skeletal muscle atrophy, muscle failure, fatigue

Even at lower doses (4 mg and 8 mg), statistically significant and clinically meaningful weight reductions were observed compared to placebo

If phentermine provided temporary results followed by complete regain, the switch to a GLP-1 approach often delivers different outcomes because the mechanism is fundamentally different

The large 2025 meta-analysis quantified this as approximately 63% higher gastrointestinal adverse event rates compared with placebo, and gallbladder disorders were about 26% higher